■天然健康产品已成为帕金森病(PD)患者的潜在症状治疗方法。
■要确定天然保健品的使用率,对天然保健品的兴趣,意识到潜在的草药-药物相互作用,以及医疗保健专业人员关于PD患者使用天然保健品的咨询。
■PRIME-NL研究中嵌入的横断面4项调查,这是一个基于人群的PD队列。
■在367名PD患者中,36%的人报告曾使用天然保健品来缓解PD相关症状,咖啡,大麻和姜黄是最受欢迎的。此外,71%的PD患者有兴趣了解更多有关天然保健品的信息。39%的天然健康产品用户知道这些产品可以与PD药物相互作用,39%的人与他们的医疗保健专业人员讨论了它们的使用。
■天然保健品通常用于缓解PD患者的症状,但是大多数用户不知道这些产品可以与PD药物相互作用,并且不与他们的医疗保健专业人员讨论他们的消费。
帕金森病是一种复杂的神经退行性疾病,目前的治疗方法仅限于症状缓解,和处方药往往会引起副作用。在这种情况下,人们对非药物干预的兴趣越来越大,帕金森病患者可能希望探索天然保健品来缓解疾病相关症状。这些产品的例子包括大麻,咖啡,或天鹅绒豆(作为左旋多巴的天然来源)。然而,目前尚不清楚有多少帕金森病患者曾经使用过,或希望使用,天然保健品可缓解疾病相关症状。此外,有限的信息可用于评估他们是否意识到这些产品与处方药之间可能的相互作用。因此,这项研究的目的是在大量具有代表性的帕金森病患者中调查这些问题.共有367人回复调查,36%的人报告说,他们使用天然保健品来缓解帕金森病相关症状。在我们调查中列出的补充剂中,咖啡(16%),大麻(13%)和姜黄(10%)是最受欢迎的。此外,71%的参与者有兴趣了解更多有关天然保健品的信息,我们发现,39%的天然健康产品使用者意识到与处方帕金森病药物的可能相互作用。然而,似乎只有39%的用户与他们的医疗保健提供者讨论过这些补充剂。这些观察是重要的,因为关于将天然健康产品整合到临床实践中的关注是它们与处方药物的潜在相互作用。因此,这些发现支持需要对这些产品的健康益处和安全性进行额外的研究。我们得出的结论是,帕金森病患者使用天然保健品来缓解症状,并鼓励与他们的医疗保健提供者进行公开讨论,以确保有效性和安全性。
UNASSIGNED: Natural health products have emerged as a potential symptomatic therapeutic approach for people with Parkinson\'s disease (PD).
UNASSIGNED: To determine the prevalence of natural health product use, interest in natural health products, awareness of potential herb-drug interactions, and consultation of healthcare professionals regarding natural health products use among people with PD.
UNASSIGNED: Cross-sectional 4-item survey embedded in the PRIME-NL study, which is a population-based cohort of PD.
UNASSIGNED: Of 367 people with PD, 36% reported having used natural health products to alleviate PD-related symptoms, with coffee, cannabis and turmeric being the most popular. Furthermore, 71% of people with PD were interested in learning more about natural health products. 39% of natural health products users were aware that these products could interact with PD medication and 39% had discussed their use with their healthcare professional.
UNASSIGNED: Natural health products are commonly used to alleviate symptoms by people with PD, but most users are unaware that these products can interact with PD medication and do not discuss their consumption with their healthcare professional.
Parkinson’s disease is a complex neurodegenerative disorder for which current treatments are limited to symptomatic relief, and prescribed medication often causes side effects. In this context, there is an increasing interest in non-pharmacological interventions, and people living with Parkinson’s disease may want to explore natural health products to alleviate disease-associated symptoms. Examples of these products include cannabis, coffee, or velvet bean (as a natural source of Levodopa). However, it remains unclear how many people with Parkinson’s disease have ever used, or wish to use, natural health products to relieve disease-related symptoms. In addition, limited information is available to evaluate whether they are aware of possible interactions between these products and prescribed medication. Therefore, the aim of this study was to investigate these questions in a large representative group of people with Parkinson’s disease. A total of 367 people responded to the survey, and 36% reported that they had used natural health products to relieve Parkinson’s disease-related symptoms. Among the supplements listed in our survey, coffee (16%), cannabis (13%) and turmeric (10%) were the most popular. Additionally, 71% of participants were interested in learning more about natural health products, and we found that 39% of natural health product users were aware of possible interactions with prescribed Parkinson’s disease medication. However, it appeared that only 39% of users had discussed these supplements with their healthcare provider. These observations are important because a concern regarding the integration of natural health products into clinical practice is their potential interactions with prescribed medication. Therefore, these findings support the need for additional research efforts into the health benefits and safety of these products. We conclude that natural health products are used by people with Parkinson’s disease to provide symptomatic relief, and open discussions with their healthcare providers are encouraged to ensure efficacy and safety.